Results 261 to 270 of about 58,152 (283)

Vectorized gene therapy of liver tumors: proof-of-concept of TG4023 (MVA-FCU1) in combination with flucytosine

Annals of Oncology, 2017
J -P Delord
exaly  

Aerosol immunization with NYVAC and MVA vectored vaccines is safe, simple, and immunogenic

Proceedings of the National Academy of Sciences of the United States of America, 2008
Carmen Elena Gomez, Sjoerd van der Burg, Mariano Esteban   +2 more
exaly  

MVA Hypothesis Testing

Matthias Fengler, Wolfgang Karl Härdle
openaire   +1 more source

MVA - Proximity Measures

Matthias Fengler, Petra Burdejova, Raul Bag, Wolfgang Karl Härdle   +3 more
openaire   +1 more source

Use of apathogenic vaccinia virus MVA expressing EHV-1 gC as basis of a combined recombinant MVA/DNA vaccination scheme

Vaccine, 2000
Birgit Strobl, Norbert Nowotny, Hartwig P Huemer   +2 more
exaly  

MVA Theory of estimation

Lennart John Baals, Matthias Fengler, Wolfgang Karl Härdle   +2 more
openaire   +1 more source

The MVA‐EVA Relationship: Separation of Market Driven Versus Firm Driven Effects

Review of Accounting and Finance, 2005
exaly  

Recombinant MVA virus, and the use thereof

1997
SUTTER GERD, OHLMANN MARION, ERFLE VOLKER   +2 more
openaire   +8 more sources

Manufacturing Value Added (MVA)

2021
openaire   +1 more source

IMPROVED MVA VACCINES

2007
FEINBERG MARK M D, GARBER DAVID
openaire   +2 more sources